Inspire Medical Systems, Inc. (INSP)
NYSE: INSP · Real-Time Price · USD
137.37
-2.70 (-1.93%)
Dec 11, 2025, 4:00 PM EST - Market closed
Inspire Medical Systems Stock Forecast
Stock Price Forecast
The 15 analysts that cover Inspire Medical Systems stock have a consensus rating of "Buy" and an average price target of $132.27, which forecasts a -3.71% decrease in the stock price over the next year. The lowest target is $82 and the highest is $216.
Price Target: $132.27 (-3.71%)
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for Inspire Medical Systems stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Jul '25 | Aug '25 | Sep '25 | Oct '25 | Nov '25 | Dec '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 3 | 2 | 2 | 3 | 3 |
| Buy | 7 | 5 | 6 | 6 | 7 | 7 |
| Hold | 3 | 6 | 7 | 8 | 5 | 6 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 12 | 14 | 15 | 16 | 15 | 16 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Piper Sandler | Piper Sandler | Buy Maintains $135 → $165 | Buy | Maintains | $135 → $165 | +20.11% | Dec 8, 2025 |
| Oppenheimer | Oppenheimer | Hold → Buy Upgrades $175 | Hold → Buy | Upgrades | $175 | +27.39% | Dec 8, 2025 |
| Baird | Baird | Buy Maintains $125 → $180 | Buy | Maintains | $125 → $180 | +31.03% | Dec 4, 2025 |
| Morgan Stanley | Morgan Stanley | Buy → Hold Downgrades $105 → $130 | Buy → Hold | Downgrades | $105 → $130 | -5.37% | Dec 2, 2025 |
| Truist Securities | Truist Securities | Hold → Strong Buy Upgrades $128 → $165 | Hold → Strong Buy | Upgrades | $128 → $165 | +20.11% | Nov 26, 2025 |
Financial Forecast
Revenue This Year
922.98M
from 802.80M
Increased by 14.97%
Revenue Next Year
1.03B
from 922.98M
Increased by 11.81%
EPS This Year
0.94
from 1.75
Decreased by -46.56%
EPS Next Year
1.74
from 0.94
Increased by 86.52%
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | 954.0M | 1.1B | ||||
| Avg | 923.0M | 1.0B | ||||
| Low | 882.0M | 976.1M |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | 18.8% | 21.7% | ||||
| Avg | 15.0% | 11.8% | ||||
| Low | 9.9% | 5.8% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | 1.65 | 2.57 | ||||
| Avg | 0.94 | 1.74 | ||||
| Low | 0.43 | 0.92 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | -5.8% | 175.1% | ||||
| Avg | -46.6% | 86.5% | ||||
| Low | -75.4% | -1.5% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.